PDS Biotechnology Corporation (PDSB) Free cash flow 2016–2025
PDS Biotechnology Corporation (PDSB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.8MFY2025 · since FY2016: -$32.9M → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +20.8% |
| FY2024 | -$35.1M | -4.2% |
| FY2023 | -$33.6M | — |
| FY2018 | -$1.6M | +96.2% |
| FY2017 | -$40.9M | -24.4% |
| FY2016 | -$32.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice